"cox proportional hazard models" trang 9 - tải miễn phí từ tailieunhanh
The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: A multi-center, hospital-based study covering 20 years of data

The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: A multi-center, hospital-based study covering 20 years of data
11    1    1
Mechanism of prognostic marker SPOCK3 affecting malignant progression of prostate cancer and construction of prognostic model

Mechanism of prognostic marker SPOCK3 affecting malignant progression of prostate cancer and construction of prognostic model
14    1    1
Occult lymph node metastasis is not a favorable factor for resected NSCLC patients

Occult lymph node metastasis is not a favorable factor for resected NSCLC patients
11    1    1
Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer

Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer
9    1    1
The optimal minimum lymph node count for carcinoembryonic antigen elevated colon cancer: A population-based study in the SEER set and External set

The optimal minimum lymph node count for carcinoembryonic antigen elevated colon cancer: A population-based study in the SEER set and External set
8    1    1
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting

Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting
9    6    1
Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): A novel prognostic factor in colorectal cancer

Tumor necrosis factor-α-inducible protein 8-like protein 3 (TIPE3): A novel prognostic factor in colorectal cancer
10    2    1
HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas

HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas
23    5    1
Association of novel and conventional obesity indices with colorectal cancer risk in older Chinese: A 14-year follow-up of the Guangzhou Biobank Cohort Study

Association of novel and conventional obesity indices with colorectal cancer risk in older Chinese: A 14-year follow-up of the Guangzhou Biobank Cohort Study
10    4    1
Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: A retrospective study

Prognostic role of CD74, CD10 and Ki-67 immunohistochemical expression in patients with diffuse malignant peritoneal mesothelioma: A retrospective study
13    4    1
ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma

ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
14    4    1
Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma

Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma
17    4    1
Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma

Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma
9    7    1
The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision

The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision
9    4    1
Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer
9    4    1
Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States

Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone as first line of therapy in the United States
9    1    1
Association between the TyG index and TG/ HDL-C ratio as insulin resistance markers and the risk of colorectal cancer

Association between the TyG index and TG/ HDL-C ratio as insulin resistance markers and the risk of colorectal cancer
11    1    1
Prognostic and clinicopathological significance of transcription factor c-Jun in hypopharyngeal squamous cell carcinoma: A 3-year follow-up retrospective study

Prognostic and clinicopathological significance of transcription factor c-Jun in hypopharyngeal squamous cell carcinoma: A 3-year follow-up retrospective study
11    1    1
Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma

Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma
16    3    1
Survival outcomes in locally advanced dMMR rectal cancer: Surgery plus adjunctive treatment vs. surgery alone

Survival outcomes in locally advanced dMMR rectal cancer: Surgery plus adjunctive treatment vs. surgery alone
11    1    1